Back to Treatments

Treatment

Daratumumab

1
Conditions
293
Trials
15K
Participants
60%
Average Safety

Condition Evidence

Multiple myeloma

293 trials · 15K participants

92% effectiveness · 60% safety
Daratumumab | DFDA